BIOMAT Database Logo BIOMAT Database Logo

[Acute viral hepatitis. Its treatment with cytosine arabinoside]. 1977

J M de la Torre Fernandez, and J Montero Vázquez, and L F Capote Armas, and A Domínguez Carmona

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008297 Male Males
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J M de la Torre Fernandez, and J Montero Vázquez, and L F Capote Armas, and A Domínguez Carmona
[Cytosine-arabinoside in the treatment of acute leukemias].
April 1972, Wiener medizinische Wochenschrift (1946),
J M de la Torre Fernandez, and J Montero Vázquez, and L F Capote Armas, and A Domínguez Carmona
Treatment of refractory acute leukaemia with high dose cytosine arabinoside.
July 1982, British journal of haematology,
J M de la Torre Fernandez, and J Montero Vázquez, and L F Capote Armas, and A Domínguez Carmona
[Treatment of acute leukemias in the infancy with cytosine arabinoside].
June 1971, Minerva pediatrica,
J M de la Torre Fernandez, and J Montero Vázquez, and L F Capote Armas, and A Domínguez Carmona
Treatment of refractory acute leukemia with high-dose cytosine arabinoside.
June 1987, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
J M de la Torre Fernandez, and J Montero Vázquez, and L F Capote Armas, and A Domínguez Carmona
[Treatment of acute myeloblastic leukemia with daunorubicin and cytosine-arabinoside].
October 1972, Ugeskrift for laeger,
J M de la Torre Fernandez, and J Montero Vázquez, and L F Capote Armas, and A Domínguez Carmona
[Clinical use of cytosine arabinoside in infancy. I. Cytosine arabinoside in the treatment of acute leukosis].
September 1975, Minerva pediatrica,
J M de la Torre Fernandez, and J Montero Vázquez, and L F Capote Armas, and A Domínguez Carmona
Treatment of smallpox with cytosine arabinoside.
December 1972, Lancet (London, England),
J M de la Torre Fernandez, and J Montero Vázquez, and L F Capote Armas, and A Domínguez Carmona
[Herpesvirus diseases in children with acute leukosis. Treatment with cytosine-arabinoside].
March 1974, Fortschritte der Medizin,
J M de la Torre Fernandez, and J Montero Vázquez, and L F Capote Armas, and A Domínguez Carmona
Herpes simplex encephalitis: treatment with adenine arabinoside and cytosine arabinoside.
February 1978, The Medical journal of Australia,
J M de la Torre Fernandez, and J Montero Vázquez, and L F Capote Armas, and A Domínguez Carmona
The cost-effectiveness of idarubicin/cytosine arabinoside versus daunorubicin/cytosine arabinoside in the treatment of adults with acute myeloid leukemia.
January 1991, Clinical therapeutics,
Copied contents to your clipboard!